Reata Pharmaceuticals
Biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
€6.0b
Enterprise valuation
€5.8b (Public information from Sep 2023)
Share price
$172.36 RETA
Plano Texas (HQ)
Authorizing premium user...